Briggs W. Morrison
2020
In 2020, Briggs W. Morrison earned a total compensation of $2.2M as Chief Executive Officer at Syndax Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $285,260 |
---|---|
Option Awards | $1,273,590 |
Salary | $600,547 |
Other | $6,000 |
Total | $2,165,397 |
Morrison received $1.3M in option awards, accounting for 59% of the total pay in 2020.
Morrison also received $285.3K in non-equity incentive plan, $600.5K in salary and $6K in other compensation.
Rankings
In 2020, Briggs W. Morrison's compensation ranked 5,172nd out of 13,090 executives tracked by ExecPay. In other words, Morrison earned more than 60.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,172 | 61st |
Manufacturing | 2,120 | 62nd |
Chemicals And Allied Products | 848 | 62nd |
Drugs | 731 | 63rd |
Pharmaceutical Preparations | 548 | 62nd |
Morrison's colleagues
We found two more compensation records of executives who worked with Briggs W. Morrison at Syndax Pharmaceuticals in 2020.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019